Cannabis/Cannabinoids Archives

The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases

Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options,

There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressing

Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term forRead

Is Cannabidiol the Next Clinical Antioxidant?

Emerging research shows that cannabidiol holds unique properties as an antioxidant. In the scientific summary, we profile two studies that review the potential of non-psychotropic cannabidiol as an antioxidant. This research has future clinical implications for cerebral ischemia, rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, theRead

Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand

In this video, Dr. DeSilva shares some case studies and how he is prescribing CBD for common conditions for his patients. In this video series he discusses the following: Case studies of patient response to CBD for sleep and auto-immunity, Researching the right brand of CBD, What to look forRead

New Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief

While cannabidiol (CBD) is fast becoming a common compound for pain and anxiety relief, the exact pathways and dosage have remained elusive. A recent study, published in the journal PAIN, identified new pathways, beyond the endocannabinoid system, which explain its analgesic and anti-anxiety benefits. They are surprisingly different than whatRead

Dr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover Cannabidiol (CBD) (CORRECTION)

BALA CYNWYD, Pa., Oct. 16, 2018 — Dr. Sanjay Gupta, President of the American Pain Association (APA)* and a pain management specialist based in Bala Cynwyd, Penn., is leading the push for insurance companies to cover cannabidiol (CBD) products for the treatment of pain and Opioid Use Disorder. Simply put,Read

Full-Spectrum Hemp for Inflammation and Sleep, Part 5 & Part 6

In these two videos, Derrick DeSilva, MD, discusses the value of full-spectrum hemp to address pain and inflammation. As he explains, full-spectrum hemp (FSH) has a novel dual mechanism of Cox-2 and Lox-5, similar to turmeric, to address pain. What you will learn: What are the mechanisms that addresses inflammationRead

Dr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4

As part of our ongoing series on full-spectrum hemp, Dr. DeSilva and Today’s Practitioner’s Rob Lutz discusses the endocannabinoid system, hemp’s role as an adaptogen, what is the dosage for full-spectrum hemp?, along with many other pearls of wisdom. Click here for Part 1 & 2, Clinical Fundamentals of Full-SpectrumRead

Clinical Fundamentals of Full-Spectrum Hemp with Dr. Derrick DeSilva, Part 1 & 2

Full-spectrum hemp is gaining a remarkable reputation among clinicians as a fundamental and safe botanical for a variety of clinical purposes. In these short videos, Derrick DeSilva, MD and Rob Lutz, founder of Today’s Practitioner, reviews the safety, side effects and clinical uses of full-spectrum hemp (cannabidiol). What you willRead

Featured Article

AHCC: Powerful Immune Support

Topics

Recent Articles

Impact of Stress Hormones on Insulin Metabolism

Peptides Unpacked: Exploring the Future of Personalized Medicine

Comprehensive Protocol for Defending Immunity

The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases

Understanding Cannabinoid Delivery Systems and Clinical Applications

Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients

Is Cannabidiol the Next Clinical Antioxidant?

Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand

New Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief

Dr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover Cannabidiol (CBD) (CORRECTION)

Full-Spectrum Hemp for Inflammation and Sleep, Part 5 & Part 6

Dr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4

Clinical Fundamentals of Full-Spectrum Hemp with Dr. Derrick DeSilva, Part 1 & 2

Copyright © 2013 - 2022 Todays Practitioner, LLC. All Rights Reserved.

Site by Quadshot Digital

JOIN OUR MAILING LIST